Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Assessment of Recurrent status, Tissue and DNA Core availability and Prostate pathology section status among men in the PLCO

Principal Investigator
Name
Scott Kelly
Degrees
Ph.D.
Institution
National Cancer Institute, NIH
Position Title
Postdoctoral Fellow
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-243
Initial CDAS Request Approval
Dec 1, 2016
Title
Assessment of Recurrent status, Tissue and DNA Core availability and Prostate pathology section status among men in the PLCO
Summary
This project will summarize the availability of prostate cancer cases who have provided genetic consent for tissue/DNA and have been selected for pathology with cores available for future testing, in conjunction with biochemical recurrence status. We will tabulate cases of each under various scenarios to gain a greater understanding for future studies of which men have tissue availability and for whom detailed information exists on biochemical recurrence status.
Aims

Aims
1. To examine the number of prostate cancer cases who have genetic consent, no prior history of any cancer, have DNA/Source material, were selected for Prostate Pathology and have Prostate DNA cores still available for future testing, stratified by biochemical recurrence status, age, race, stage, gleason primary and secondary score and underlying cause of death.

Collaborators

Dr. Michael B. Cook, Investigator